Table 4.
The univariate and multivariate analysis of prognostic factors for 5-year OS.
| Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | p-value | HR | 95%CI | p-value | |
| Age, yrs; ≤ 66, > 66 | 1.52 | 0.677–2.366 | 0.098 | |||
| Males/females | 1.26 | 0.701–2.340 | 0.461 | |||
| BMI, ≤ 22/ > 22 | 0.98 | 0.548–1.778 | 0.965 | |||
| Tumor location, right side/left side | 1.54 | 0.354–1.181 | 0.156 | |||
| Histology, well or moderate/others | 2.12 | 1.023–4.415 | 0.043 | 1.59 | 0.89–2.82 | 0.120 |
| Depth of tumor invasion, T1–T2/T3–T4 | 3.05 | 1.360–6.823 | 0.002 | 3.51 | 0.69–3.80 | 0.244 |
| Lymph node metastasis, − / + | 2.42 | 1.344–4.357 | 0.003 | 2.24 | 1.28–2.96 | 0.041 |
| Lymph invasion, − / + | 2.55 | 1.385–4.700 | 0.002 | 1.89 | 0.76–2.97 | 0.236 |
| Venous invasion, − / + | 2.32 | 1.078–4.972 | 0.019 | 1.50 | 0.57–2.87 | 0.230 |
| CEA level, normal /high | 2.92 | 1.625–5.241 | 0.0004 | 1.61 | 1.40–4.66 | 0.002 |
| CA19-9 level, normal /high | 2.36 | 1.217–4.570 | 0.021 | 1.39 | 0.83–2.33 | 0.209 |
| SIRI | 2.11 | 1.122–3.965 | 0.018 | 1.60 | 1.03–2.43 | 0.048 |
BMI Body mass index, CEA Carcinoembryonic antigen, CA19-9 Carbohydrate antigen 19–9, SIRI Systemic inflammation response index.